BBIXF OTC
Bonus Biogroup Ltd.
1W: +0.0%
1M: +0.0%
3M: -63.6%
YTD: -50.0%
1Y: -42.9%
3Y: +33.3%
5Y: -60.0%
$0.04
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$21M
+19.0% ▲
Capital Expenditures
$342K
+58.5% ▲
5Y CAGR: +12.8%
Free Cash Flow
-$22M
+20.2% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$6M
+85.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$22M | -$90M | -$39M | -$29M | -$28M |
| Depreciation & Amort. | $1M | $1M | $3M | $3M | $3M |
| Stock-Based Comp. | $2M | $10M | $8M | $1M | $2M |
| Change in Working Capital | $318K | -$8M | -$1M | -$1M | $2M |
| Other Non-Cash Items | $660K | $23M | -$8K | -$745K | -$47K |
| Operating Cash Flow | -$16M | -$40M | -$29M | -$26M | -$21M |
| — Investing Activities — | |||||
| Capital Expenditures | -$254K | -$6M | -$6M | -$824K | -$342K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | -$367K | $0 | -$13M | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $13M |
| Other Investing | $0 | $0 | $96K | $0 | $0 |
| Investing Cash Flow | -$254K | -$6M | -$6M | -$14M | $13M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$670K | -$2M | -$1M | -$1M | -$1M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $4M | $0 | $0 | $0 |
| Financing Cash Flow | $32M | $113M | $2M | -$1M | $3M |
| Net Change in Cash | $16M | $63M | -$26M | -$41M | -$6M |
| Cash End of Period | $16M | $80M | $54M | $13M | $7M |
| Free Cash Flow | -$16M | -$46M | -$35M | -$27M | -$22M |